Thrombosis in situ can usually receive initial medical treatment with intravenous heparin targeting an activated partial thromboplastin time of 2.0–3.0, antiplatelet agents, high-dose statins, intravenous fluids to avoid dehydration, correction of anaemia, oxygen and sometimes prostaglandins such as iloprost.